Cryoprecipitate is a source contains following EXCEPT-
**Core Concept**
Cryoprecipitate is a blood product derived from plasma that has been frozen and then thawed. It is rich in clotting factors, particularly fibrinogen, factor VIII, and von Willebrand factor, which are essential for hemostasis.
**Why the Correct Answer is Right**
Cryoprecipitate is used to replace these clotting factors in patients with bleeding disorders, such as hemophilia A and von Willebrand disease. The process of cryoprecipitation involves the formation of a precipitate from the plasma proteins during the freezing and thawing process, which concentrates the desired clotting factors. The concentrated clotting factors in cryoprecipitate are then used to treat bleeding episodes or to prevent excessive bleeding in surgical patients.
**Why Each Wrong Option is Incorrect**
**Option A:** Factor XIII - While cryoprecipitate does contain some factor XIII, it is not the primary component of this blood product. Factor XIII is involved in stabilizing fibrin clots, but it is not the main reason for using cryoprecipitate.
**Option B:** von Willebrand factor - Cryoprecipitate is actually a rich source of von Willebrand factor, which is essential for platelet adhesion and aggregation.
**Option C:** Prothrombin complex concentrate (PCC) - Cryoprecipitate and PCC are two different blood products. PCC is used to replace multiple clotting factors, including factors II, VII, IX, and X, whereas cryoprecipitate is primarily used for fibrinogen and factor VIII replacement.
**Clinical Pearl / High-Yield Fact**
Cryoprecipitate is often used in emergency situations, such as massive transfusion protocols or in patients with severe bleeding who require rapid replacement of clotting factors. It is essential to note that cryoprecipitate should only be used under the guidance of a qualified healthcare professional.
**Correct Answer: A. Factor XIII. Factor XIII is not the primary component of cryoprecipitate.**